Avenue Therapeutics

(OTC) ATXI

Current Price$0.55

Market Cap$1.81M

Since IPO (2017)-100%

5 Year-100%

1 Year+139%

1 Month+90%

Avenue Therapeutics Financials at a Glance

Market Cap

$1.81M

Revenue (TTM)

$1.40M

Net Income (TTM)

$2.91M

EPS (TTM)

$-0.96

P/E Ratio

-0.58

Dividend

$0.00

Beta (Volatility)

0.86 (Low)

Dividend

$0.00

Beta (Volatility)

0.86 (Low)

Price

$0.55

Volume

1,098

Open

$0.55

Price

$0.55

Volume

1,098

Open

$0.55

Previous Close

$0.55

Daily Range

$0.55 - $0.55

52-Week Range

$0.15 - $0.97

Dividend

$0.00

Beta (Volatility)

0.86 (Low)

Price

$0.55

Volume

1,098

Open

$0.55

Previous Close

$0.55

Daily Range

$0.55 - $0.55

52-Week Range

$0.15 - $0.97

ATXI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Avenue Therapeutics

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Alexandra MacLean, MD, MBA

Website

www.avenuetx.com

Headquarters

New York City, NY 10036, US

ATXI Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

-2%

Net Income Margin

-2%

Return on Equity

-126%

Return on Capital

-2%

Return on Assets

-99%

Earnings Yield

-1.72%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.81M

Shares Outstanding

3.29M

Volume

1.10K

Avg. Volume

6.25K

Financials (TTM)

Gross Profit

$1.40M

Operating Income

$3.29M

EBITDA

$3.29M

Operating Cash Flow

$1.83M

Capital Expenditure

$0.00

Free Cash Flow

$1.83M

Cash & ST Invst.

$2.85M

Total Debt

$0.00

Avenue Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$1.40M

N/A

Gross Margin

0.00%

N/A

Market Cap

$1.81M

N/A

Market Cap/Employee

$906.05K

N/A

Employees

N/A

Net Income

$709.00K

+54.1%

EBITDA

$955.00K

+38.7%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$2.85M

+10.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-99.25%

N/A

Return on Invested Capital

-1.79%

N/A

Free Cash Flow

$854.00K

-11.8%

Operating Cash Flow

$854.00K

-11.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NCELNewcelX Ltd.

NCELNewcelX Ltd.$4.09+19.59%

DRMADermata Therapeutics, Inc.

DRMADermata Therapeutics, Inc.$1.27+0.79%

WINTWindtree Therapeutics, Inc.

WINTWindtree Therapeutics, Inc.$0.02-0.20%

GTBPGT Biopharma, Inc.

GTBPGT Biopharma, Inc.$0.28+3.57%

VRAXVirax Biolabs Group Limited

VRAXVirax Biolabs Group Limited$0.13-5.78%

PBMPsyence Biomedical Ltd.

PBMPsyence Biomedical Ltd.$5.30+4.28%

CARMCarisma Therapeutics, Inc.

CARMCarisma Therapeutics, Inc.$0.00-16.67%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$62.03+0.00%

HCAIHuachen Ai Parking Management Technology

HCAIHuachen Ai Parking Management Technology$10.75+0.97%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.53+0.08%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.19+0.02%

OWLBlue Owl Capital

OWLBlue Owl Capital$10.06+0.13%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$52.90-0.00%

MSFTMicrosoft

MSFTMicrosoft$405.08-0.05%

Questions About ATXI

What is the current price of Avenue Therapeutics?

Avenue Therapeutics is trading at $0.55 per share.

What is the 52-week range for Avenue Therapeutics?

Over the past 52 weeks, Avenue Therapeutics has traded between $0.15 and $0.97.

How much debt does Avenue Therapeutics have?

As of the most recent reporting period, Avenue Therapeutics reported total debt of N/A.

How much cash does Avenue Therapeutics have on hand?

Avenue Therapeutics reported $2.85M in cash and cash equivalents in its most recent financial results.

What is Avenue Therapeutics’s dividend yield?

Avenue Therapeutics does not currently have a dividend yield.

Avenue Therapeutics

Avenue Therapeutics Financials at a Glance

ATXI News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Avenue Therapeutics

ATXI Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Avenue Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ATXI

What is the current price of Avenue Therapeutics?

What is the 52-week range for Avenue Therapeutics?

How much debt does Avenue Therapeutics have?

How much cash does Avenue Therapeutics have on hand?

What is Avenue Therapeutics’s dividend yield?

Premium Investing Services